Literature DB >> 1427647

The GH-transgenic mouse as an experimental model for growth research: clinical and pathological studies.

R Wanke1, E Wolf, W Hermanns, S Folger, T Buchmüller, G Brem.   

Abstract

The objectives and the methodology of mammalian gene transfer are discussed and findings in growth hormone (GH) transgenic mice are reported to illustrate the potential offered by genetically designed animal models for investigations in various areas of biomedical research. Transgenic mice expressing hybrid genes composed of either human or bovine GH coding sequences fused to the mouse metallothionein I promoter show high serum levels of heterologous GH, increased growth rates and final adult size, decreased life expectancy and a variety of pathological changes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427647     DOI: 10.1159/000182406

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  19 in total

Review 1.  Hormonal regulation of longevity in mammals.

Authors:  Holly M Brown-Borg
Journal:  Ageing Res Rev       Date:  2007-02-20       Impact factor: 10.895

Review 2.  Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.

Authors:  Shoshana Yakar; Olle Isaksson
Journal:  Growth Horm IGF Res       Date:  2015-09-28       Impact factor: 2.372

3.  Actions and interactions of growth hormone and insulin-like growth factor-II: body and organ growth of transgenic mice.

Authors:  A Blackburn; A Schmitt; P Schmidt; R Wanke; W Hermanns; G Brem; E Wolf
Journal:  Transgenic Res       Date:  1997-05       Impact factor: 2.788

4.  Identification of differentially expressed genes in the kidneys of growth hormone transgenic mice.

Authors:  K T Coschigano; A N Wetzel; N Obichere; A Sharma; S Lee; R Rasch; M M Guigneaux; A Flyvbjerg; T G Wood; J J Kopchick
Journal:  Growth Horm IGF Res       Date:  2010-07-23       Impact factor: 2.372

5.  Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector rabphilin-3a.

Authors:  Maria Pia Rastaldi; Silvia Armelloni; Silvia Berra; Min Li; Marzia Pesaresi; Helga Poczewski; Brigitte Langer; Dontscho Kerjaschki; Anna Henger; Simone Monika Blattner; Matthias Kretzler; Rudiger Wanke; Giuseppe D'Amico
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

6.  Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

Authors:  S V Lim; M Marenzana; M Hopkinson; E O List; J J Kopchick; M Pereira; B Javaheri; J P Roux; P Chavassieux; M Korbonits; C Chenu
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

Review 7.  Hormonal control of aging in rodents: the somatotropic axis.

Authors:  Holly M Brown-Borg
Journal:  Mol Cell Endocrinol       Date:  2008-07-11       Impact factor: 4.102

8.  Do long-lived mutant and calorie-restricted mice share common anti-aging mechanisms?--a pathological point of view.

Authors:  Yuji Ikeno; Christie M Lew; Lisa A Cortez; Celeste R Webb; Shuko Lee; Gene B Hubbard
Journal:  Age (Dordr)       Date:  2006-06-02

9.  Systemic overexpression of growth hormone (GH) in transgenic FVB/N inbred mice: an optimized model for holistic studies of molecular mechanisms underlying GH-induced kidney pathology.

Authors:  Dagmar C von Waldthausen; Marlon R Schneider; Ingrid Renner-Müller; Dirk N Rauleder; Nadja Herbach; Bernhard Aigner; Rüdiger Wanke; Eckhard Wolf
Journal:  Transgenic Res       Date:  2007-12-20       Impact factor: 2.788

10.  Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice.

Authors:  Yuji Ikeno; Gene B Hubbard; Shuko Lee; Lisa A Cortez; Christie M Lew; Celeste R Webb; Darlene E Berryman; Edward O List; John J Kopchick; Andrzej Bartke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-19       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.